RALEIGH, N.C. — North Carolina is a hub for medicine, and a new study is showing promise for tracking head and neck cancer after treatment. 

  • Researchers at the UNC Lineberger Comprehensive Cancer Center presented their findings
  • The findings demonstrated a particular test could be an effective and less costly alternative for monitoring cancer recurrence
  • Click here for more information on the study

Researchers at the UNC Lineberger Comprehensive Cancer Center presented their findings at the 60th Annual Meeting of the American Society for Radiation Oncology. 

According to researchers, “The study evaluated blood tests for HPV-linked oropharyngeal squamous cell carcinoma, which is a cancer of the back of the throat. The findings demonstrated the test could be an effective and less costly alternative for monitoring cancer recurrence after radiation treatment.”

Spectrum News anchor Caroline Blair sat down with Dr. Bhishamijt Chera, radiation oncologist and researcher with the cancer center for a look at what this means for future treatment and costs.

Click here for more information on the study.